Premium
Hepatitis E virus ORF 1 induces proliferative and functional T‐cell responses in patients with ongoing and resolved hepatitis E
Author(s) -
AlAyoubi Jana,
Behrendt Patrick,
Bremer Birgit,
Suneetha Pothakamuri Venkata,
Gisa Anett,
Rinker Franziska,
Manns Michael P.,
Cornberg Markus,
Wedemeyer Heiner,
Kraft Anke R. M.
Publication year - 2018
Publication title -
liver international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.873
H-Index - 110
eISSN - 1478-3231
pISSN - 1478-3223
DOI - 10.1111/liv.13521
Subject(s) - hepatitis e virus , virology , hepatitis e , t cell , biology , antigen , cd8 , immunology , genotype , immune system , gene , genetics
Background and Aims Hepatitis E virus ( HEV ) is a major cause of acute viral hepatitis with >3 million symptomatic cases per year accounting for 70 000 HEV ‐related deaths. HEV ‐specific T‐cell responses have been investigated against structural proteins expressed by open reading frames ( ORF ) 2 and 3. T‐cell responses against non‐structural HEV proteins encoded by ORF 1 are hardly studied. The aim of this study was to determine HEV ORF 1‐specific T‐cell responses in comparison to ORF 2/3 in patients exposed to HEV . Methods HEV ‐specific CD 4 + and CD 8 + T‐cell responses against HEV genotype 3 were investigated in patients with acute and chronic hepatitis E as well as in HEV seropositive and seronegative individuals. HEV ‐specific T‐cell responses were determined by proliferation and intracellular cytokine assay upon stimulation of PBMC s with HEV ‐specific overlapping peptide pools spanning the entire HEV genome. HEV ‐antigen was measured using an anti‐ HEV antigen‐specific ELISA . Results Broad HEV ORF 1‐specific T‐cell responses were detected in patients with acute, resolved and chronic hepatitis E without distinct dominant regions. The magnitude and frequency in recognition of ORF 1‐specific T‐cell responses were similar compared to responses against HEV ORF 2/3. Longitudinal studies of HEV ‐specific T‐cell responses displayed similar behaviour against structural and non‐structural proteins. HEV ‐antigen levels were inversely correlated with HEV ‐specific T‐cell responses. Conclusions HEV ‐specific T‐cell responses are detectable against the entire HEV genome including the non‐structural proteins. HEV ‐specific T‐cell responses are associated with control of HEV infection. These findings have implications for the design of HEV vaccines.